XBiotech Inc. (NASDAQ: XBIT)
$4.2400
+0.0100 ( -0.24% ) 8.2K
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
Market Data
Open
$4.2400
Previous close
$4.2300
Volume
8.2K
Market cap
$128.95M
Day range
$4.1650 - $4.3840
52 week range
$3.5100 - $9.9600
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 44 | Nov 13, 2024 |
| 10-q | Quarterly Reports | 44 | Aug 12, 2024 |
| 4 | Insider transactions | 1 | Jun 21, 2024 |
| 4 | Insider transactions | 1 | Jun 21, 2024 |
| 4 | Insider transactions | 1 | Jun 21, 2024 |
| 4 | Insider transactions | 1 | Jun 21, 2024 |
| 8-k | 8K-related | 13 | Jun 20, 2024 |
| 10-q | Quarterly Reports | 44 | May 10, 2024 |
| def | Proxies and info statements | 5 | May 01, 2024 |
| ars | Annual reports | 1 | May 01, 2024 |